Overview

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Status:
Completed
Trial end date:
2016-05-05
Target enrollment:
Participant gender:
Summary
Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited